Literature DB >> 16084398

Cloning, expression, characterization, and crystallization of a glutaminyl cyclase from human bone marrow: a single zinc metalloenzyme.

Kai-Fa Huang1, Yi-Liang Liu, Andrew H-J Wang.   

Abstract

Glutaminyl cyclase (QC) catalyzes the N-terminal pyroglutamate formation of numerous hormones and peptides from their glutaminyl precursor. Pyroglutamate is a posttranslational or cotranslational modification important in many physiological and pathological processes. Here, we present the cloning of a QC cDNA from human bone marrow cDNA library. The protein was expressed in Escherichia coli system with the yields higher than approximately 10 mg/L bacterial culture, using a thioredoxin-tagged expression vector with several modifications. Based on high histidine content ( approximately 5%) of the protein, a convenient purification step by Ni-affinity chromatography was designed, leading to near homogeneity of the purified human QC. The identity of the recombinant human QC was confirmed by mass spectrometry and circular dichroism spectroscopy. The enzyme was active on both synthetic and physiological substrates, and the activity could be inhibited by several imidazole, triazole, and tetrazole derivatives. An atomic absorption analysis demonstrated that human QC contains one zinc ion per protein molecule. We also obtained the human QC crystals, which belong to cubic, tetragonal, and rhombohedral forms. Our works are useful to acquire new insights into human and animal QCs, particularly for future structural analysis and inhibitor designs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084398     DOI: 10.1016/j.pep.2005.02.020

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding.

Authors:  Kai-Fa Huang; Su-Sen Liaw; Wei-Lin Huang; Cho-Yun Chia; Yan-Chung Lo; Yi-Ling Chen; Andrew H-J Wang
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

2.  Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation.

Authors:  Kai-Fa Huang; Yi-Liang Liu; Wei-Ju Cheng; Tzu-Ping Ko; Andrew H-J Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-31       Impact factor: 11.205

3.  High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase (PyrC) as a cleavable His-SUMO fusion.

Authors:  Lena Truong; Kirk E Hevener; Amy J Rice; Kavankumar Patel; Michael E Johnson; Hyun Lee
Journal:  Protein Expr Purif       Date:  2012-12-13       Impact factor: 1.650

4.  Molecular characterization of tick salivary gland glutaminyl cyclase.

Authors:  Steven W Adamson; Rebecca E Browning; Chien-Chung Chao; Robert C Bateman; Wei-Mei Ching; Shahid Karim
Journal:  Insect Biochem Mol Biol       Date:  2013-06-13       Impact factor: 4.714

5.  The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease.

Authors:  Flavio DiPisa; Cecilia Pozzi; Manuela Benvenuti; Matteo Andreini; Guido Marconi; Stefano Mangani
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-07-28       Impact factor: 1.056

6.  Microarray evidence of glutaminyl cyclase gene expression in melanoma: implications for tumor antigen specific immunotherapy.

Authors:  John Stuart Gillis
Journal:  J Transl Med       Date:  2006-07-04       Impact factor: 5.531

7.  Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases.

Authors:  Cheng-Yang Huang
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

8.  Mutagenesis of Trichoderma reesei endoglucanase I: impact of expression host on activity and stability at elevated temperatures.

Authors:  Harshal A Chokhawala; Christine M Roche; Tae-Wan Kim; Meera E Atreya; Neeraja Vegesna; Craig M Dana; Harvey W Blanch; Douglas S Clark
Journal:  BMC Biotechnol       Date:  2015-02-21       Impact factor: 2.563

9.  Soluble variants of human recombinant glutaminyl cyclase.

Authors:  Cristiana Castaldo; Silvia Ciambellotti; Raquel de Pablo-Latorre; Daniela Lalli; Valentina Porcari; Paola Turano
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.